• nl

News

BioBTX commences operation of pilot plant for production of sustainable platform chemicals

13 September 2018 / Latest news

Read more

Carduso Capital invests in “AGILeBiotics”

20 July 2018 / Latest news

Read more

Carduso Capital invests in “CC Diagnostics”

17 July 2018 / Latest news

Carduso Capital invests in the Groningen start-up CC Diagnostics that is developing an unique test kit for detection of early stage cervical cancer. Cervical cancer is a worldwide problem, but in population-based screening programs the incidence of cervical cancers has decreased significantly in the last decades. With regular screening, the early precancerous changes in cervical cells can be detected and treated, and consequently preventing the development of cervical cancer.

Read more

Carduso Capital invests in “Brainscan”

26 January 2018 / Latest news

Read more

BiOrion Technologies receives an EFRO TENDER VALORISATIE 2017 grant for its € 1.0 million cardiac fibrosis imaging program.

18 January 2018 / Latest news

Read more

Leading European universities, research organizations and industrial entities team up to revolutionize lung cancer treatment

12 December 2017 / Latest news

Read more

CARDUSO CAPITAL INVESTS IN BIOBTX

16 October 2017 / Latest news

Read more

Carduso Capital Groningen invests in DEAM Holding BV.

16 October 2017 / Latest news

Read more

Carduso Capital invests in “Gum Irrigator”

12 October 2017 / Latest news

Gum Irrigator B.V. is a family holding based in Groningen, the Netherlands. The Gum Irrigator apparatus provides an effective, pain-free and non-invasive solution in the treatment of gum problems with natural teeth (periodontitis) and implants (peri-implantitis). Therefore, the Gum Irrigator will provide easier access to subgingival cleaning to a larger part of the population. According to the statistics of the World Health Organization 15-20% of the adult population suffers from severe gum problems.

Read more

Pieter Imhof appointed Chief Executive Officer BioBTX B.V.

11 October 2017 / Latest news

BioBTX B.V. has announced that starting 15 September 2017 Mr. Pieter Imhof has been appointed Chief Executive Officer (CEO) of BioBTX BV. In this role Mr Imhof will especially focus on the further upscaling and commercialization of the BioBTX technology.

Read more